Lyra Therapeutics Inc Sustainability Reports
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing long-acting, localized, anti-inflammatory sinonasal implants. Its drug-delivery candidates are engineered to provide sustained treatment for patients suffering from chronic rhinosinusitis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001V0GBW5
3 reports from 2020 to 2023
Company Profile
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing long-acting, localized, anti-inflammatory sinonasal implants. Its drug-delivery candidates are engineered to provide sustained treatment for patients suffering from chronic rhinosinusitis.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
